NCT00524472View on ClinicalTrials.gov

Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

1,439

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Cardiac Surgery
Interventions
OTHER

Hyperinsulinemic-normoglycemic clamp

Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.

OTHER

insulin at the standard of care levels

Subjects will be administered insulin at the standard of care levels established by the participating institution.

Trial Locations (2)

44195

Cleveland Clinic, Cleveland

H3A 1A1

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00524472 - Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery | Biotech Hunter | Biotech Hunter